Table 3.
Potential advantages of roxadustat based on clinical trials
| Potential advantages of roxadustat |
|---|
| − Increases or maintains Hb levels effectively |
| − Increases endogenous EPO expression in physiological range |
| − Regulates iron metabolism (hepcidin reduction in particular) |
| − Increases iron absorption and is not influenced by inflammation |
| − Oral route |
| − Inhibits HIF-PHD reversibly and transiently |
| − No risk of hypertension |
| − Lowering of cholesterol levels |
| − Avoidance of high EPO levels |
| − Avoidance of side effects induced by iron supplementation |
EPO, erythropoietin; Hb, hemoglobin; HIF-PHD, hypoxia-inducible factor-prolyl hydroxylase domain.